The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Is 2.5mg Mounjaro Effective for Weight Loss?
The 2.5mg dose of Mounjaro (tirzepatide) is a prescription-only starting dose, not a maintenance dose — and it's not designed to be your final therapeutic dose. Clinical evidence shows that meaningful weight loss typically occurs at higher doses, with most users needing to reach 10mg or 15mg for significant results. However, the 2.5mg starting dose plays an important role in your treatment journey. This guide explains how the starting dose works, what effectiveness looks like at this level, and how your prescriber will help you progress to a more effective dose based on your individual response and tolerance.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How the 2.5mg Starting Dose Works
Mounjaro operates on a dose titration schedule, meaning your dose increases gradually every four weeks. You start at 2.5mg for weeks 1–4 to allow your body to adjust and for your prescriber to monitor how you respond. The 2.5mg dose is low enough that side effects (like nausea or stomach upset) are typically minimal, making it a safer entry point.
At 2.5mg alone, weight loss results are modest — most people don't see significant results at this dose. The clinical trial data (SURMOUNT-1) shows that participants on the full 15mg maintenance dose lost an average of 20.9% of their body weight over 72 weeks. At 2.5mg, losses are much smaller because the appetite-suppressing effect is gentler. Your prescriber will increase your dose every four weeks — moving to 5mg, then 7.5mg, then 10mg, and potentially up to 15mg — to find the dose that gives you the best balance of effectiveness and tolerability.
Think of 2.5mg as a trial and adjustment phase, not your final treatment. The goal is to reach a higher maintenance dose where clinical effectiveness has been proven.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
What to Expect at 2.5mg — Effectiveness Reality
At 2.5mg, you may notice early appetite reduction and possibly a slight reduction in food cravings, but substantial weight loss is unlikely at this dose alone. Most people see minimal changes on 2.5mg — perhaps 1–2 lbs over four weeks, or none at all. This is normal and expected. Your prescriber knows that this dose is just the beginning.
What matters is how your body tolerates the medication. If you experience manageable side effects and no safety concerns, your dose will increase. If side effects are problematic, your prescriber may extend the time at 2.5mg or adjust the escalation plan. The 2.5mg starting dose is clinically proven to be safe and sets the foundation for reaching the doses where real effectiveness emerges — typically 10mg and above. Use our free GLP-1 weight loss calculator to see projected outcomes at different doses, and speak with your prescriber about your personalised escalation schedule.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is 2.5mg Mounjaro enough to lose weight?
2.5mg is a starting dose, not a treatment dose. Weight loss at 2.5mg is typically minimal (if any). Most users need to progress to 5mg, 10mg, or 15mg for meaningful weight loss. Your prescriber will increase your dose every four weeks based on your response and tolerance.
How long do I stay on 2.5mg Mounjaro?
You remain on 2.5mg for four weeks (weeks 1–4), then your dose increases to 5mg in weeks 5–8. Each dose escalation is four weeks, allowing your body to adapt. However, if you experience side effects, your prescriber may extend this timeline.
How does 2.5mg Mounjaro compare to Wegovy for weight loss?
Mounjaro is a dual GIP/GLP-1 receptor agonist, whereas Wegovy (semaglutide) is a GLP-1 agonist only. At equivalent maintenance doses, Mounjaro showed slightly higher average weight loss in trials (~20.9% vs ~14.9%), but 2.5mg of either medication is still a starting dose with modest individual results.
Why do I need a Mounjaro KwikPen if 2.5mg isn't effective?
Each KwikPen contains four weekly doses. Your first pen delivers four 2.5mg injections (one per week for four weeks). After week 4, you'll need a second pen to administer the higher doses. The KwikPen is a delivery device; the dose progression is what drives effectiveness.
Should I ask my prescriber to skip 2.5mg and start at a higher dose?
No. The 2.5mg starting dose is part of the established, evidence-based escalation protocol. It allows your body to tolerate the medication safely and helps your prescriber monitor your response. Starting higher increases side effect risk without improving effectiveness. Your GP or prescriber will follow the clinical titration schedule.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.